Abstract

This contract, entitled Development of Valortim: a Human Monoclonal Antibody for the Treatment of Inhalational Anthrax, supports the advanced development of Valortim as a therapeutic agent for inhalational anthrax.

  Funding Agency

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research and Development Contracts (N01)
Project #
272200700033C-2-0-1
Application #
7695830
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2008
Total Cost
$1,998,109
Indirect Cost

  Institution

Name
Pharmathene, Inc.
Department
Type
DUNS #
082804936
City
Annapolis
State
MD
Country
United States
Zip Code
21401